hematological cancersolid tumorsgraft-versus-host diseasesolid cancerChimeric antigen receptor T (CAR-T) cell therapiesxenograft mouse models
… that has shown promising clinical efficacy, especially against hematological cancer, with multiple FDA-approved therapies. Current autologous CART …